Après-demain

Family-owned Swiss group with life science, impact capital management and philanthropy divisions

+ Add to sales board

Highlights

  • Hiring2 open roles
  • New on EvolcAdded 2026-10-29

About Après-demain

Après-demain is a private, family-owned group based in Switzerland. Its Life Science pole is Debiopharm, which develops therapies in oncology and infectious diseases. The group also runs asset diversification divisions and a philanthropy division.

Capital management activities include Responsible Capital Management, set up in the early 2000s to diversify assets and generate additional income, and Impactful Capital Management, created in 2020 to address climate and precarious living conditions. The philanthropy division has supported local and international projects since 2010.

The Life Science business was created in 1979 by Dr Rolland-Yves Mauvernay and joined by his son Thierry Mauvernay in 2001. Open positions are listed in Lausanne, in private equity and finance.

Product: Life Science therapy development in oncology and infectious diseases (Debiopharm), plus capital management and philanthropy divisions.

Jobs at Après-demain (2)

Après-demain is hiring for 2 roles in finance, based in Lausanne.

More biotech & pharma companies

  • Artidis

    Nanomechanical cancer research devices and data software for researchers, laboratories and clinical investigators
    SwitzerlandBiotech & pharma13 open jobs
  • Athebio

    Biotherapeutics developer building DARPin-based drug candidates on its Athebody platform for drug developers
    SwitzerlandBiotech & pharma1 open job
  • CASCINATION

    Robotic and image-guided surgical systems for cancer ablation and cochlear implantation, sold to clinicians
    SwitzerlandBiotech & pharma5 open jobs
    New on Evolc
  • Celonic

    Biologics development and manufacturing services for biotech and biosimilar companies
    SwitzerlandBiotech & pharma4 open jobs
    New on Evolc
  • Debiopharm

    Develops and licenses medicines for pharmaceutical partners and invests in digital health ventures
    SwitzerlandBiotech & pharma7 open jobs
  • Ridgelinediscovery

    Creates and operates new drug discovery biotech companies with academic founders, backed by Versant Ventures, from Basel
    SwitzerlandBiotech & pharma6 open jobs

All biotech & pharma companies →

Website technologies

Older, unverified list. Detection dates and supporting evidence are not yet available.

  • Cloudflare
  • Google Tag Manager
  • Google reCAPTCHA
  • WordPress
  • Workable
  • jQuery